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Abstract
Background: Hospitalisations are a critical event in the care process. Insufficient communication and
uncoordinated follow-up care often impede the recovery process of the patient resulting in a high number of
rehospitalisations and increased health care costs. The overall aim of this study is the development, implementation
and evaluation of a structured programme (VESPEERA) to improve the admission and discharge process.
Methods: We will conduct an open quasi-experimental multi-centre study with four intervention arms. A cohort
selected from insurance claims data will serve as a control group reflecting usual care. The intervention will be
implemented in 25 hospital departments and 115 general practices in 9 districts in Baden-Wurttemberg. Eligibility
criteria for patients are: age > 18 years, hospital admission or hospitalisation, insurance at the sickness fund “AOK
Baden-Wurttemberg”, enrolment in general practice-centred care contract. Each study arm will receive different
intervention components based on the point of study enrolment and the patient’s medical need. The interventions
comprise a) a structured assessment in the general practice prior to admission resulting in an admission letter b) a
discharge conversation by phone between hospital and general practice, c) a structured assessment and care plan
post-discharge and d) telephone monitoring for patients with a high risk of rehospitalisation. The assessments are
supported by a software tool (“CareCockpit”), originally developed for structured case management programmes.
The primary outcome (rehospitalisation due to the same indication within 90 days) and a range of secondary
outcomes (rehospitalisation due to the same indication within 30 days; hospitalisations due to ambulatory care-
sensitive conditions; delayed prescription of medication and medical products/ devices and referral to other health
practitioner/s after discharge; utilisation of emergency or rescue services within 3 months; average care cost per
year and patient participating in the VESPEERA programme) and quality indicators will be determined based on
insurance claims data and CareCockpit data. Additionally, a patient survey on satisfaction with cross-sectoral care
and health related quality of life will be conducted.
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Discussion: Based on the results, area-wide implementation in usual care is well sought. This study will contribute
to an improvement of cross-sectoral care during the admission and discharge process.
Trial registration: DRKS00014294 on DRKS / Universal Trial Number (UTN): U1111–1210-9657, Date of registration
12/06/2018.
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Background
Hospital discharges are a critical moment in healthcare
delivery as continuity of care is crucial for patient safety.
In daily practice, patients are often discharged at short
notice, resulting in a lack of coordination of follow-up
care and sufficient communication between care pro-
viders of the inpatient and outpatient sector and to the
patient [1–3]. This can be due to different organisational
procedures and different views on the patient and re-
sponsibilities with regard to the care process between
hospitals and general practices [4] as well as between in-
terprofessional teams [5]. The resulting interruptions in
the continuity of care can affect the recovery process
and healthcare related patient satisfaction. At worst, they
can lead to avoidable rehospitalisations and adverse
events [1, 4], which are relevant clinical outcomes and
associated with increased care costs.
A project on harmonisation of admission and dis-
charge medication showed the need for improvement of
information brokerage concerning pre- and post- hos-
pital medication as well as structured medication coun-
seling after discharge [3].
Structured admission and discharge management are es-
sential and inseparable components of optimal transitional
care. Numerous systematic reviews provide overviews on
evaluated transitional care programmes. For example, Lep-
pin et al. found that a multicomponent intervention com-
prising many care providers with components such as case
management, a telephone follow-up, patient-centred dis-
charge information, and patient education significantly re-
duced readmission rates for medical and surgical patients
[6]. In another review, Branowicki and colleagues imple-
mented post-discharge interventions like follow-up phone
calls, home visits, and discharge education [7]. The inter-
vention showed that home visits and having two or more
follow-up phone calls significantly reduced readmission
rates. Vedel et al. conducted a review with studies focusing
on transitional care interventions for patients with heart
failure [8]. Intervention components included in the studies
were telephone follow-up, individualised treatment plans,
and medication schedules. The authors found that high in-
tensity interventions significantly reduced readmission
rates. Furthermore, they found a significant effect on
reduction of emergency department visits. The results of
Hansen et al. indicate that early discharge planning,
follow-up phone calls and patient-centred discharge in-
structions may reduce 30-day rehospitalisation rates [9]. In
another systematic review, Hesselink and colleagues gather
studies that suggest structured discharge information, co-
ordination of follow-up care and timely communication be-
tween care providers are components of successful
discharge interventions [4]. Burke et al. found interventions
in the domain “Systems for Monitoring and Managing
Symptoms” of the Ideal Transitions Framework to be suc-
cessful in reducing rehospitalisation rates [10]. Bahr et al.
investigated post discharge telephone calls in single compo-
nent interventions but could not find clear evidence on
their effectiveness on reducing rehospitalisation rates and
emergency department use and increasing patient satisfac-
tion [11]. However, the authors suggest that further re-
search should focus on telephone calls as a component of
complex interventions involving outpatient care providers
and high risk patients. In many systematic reviews, authors
cannot draw firm conclusions, because the intervention
components of the included studies are very heterogeneous
and often lack comprehensible descriptions [4, 9, 12].
Nevertheless, some authors indicate that multicomponent
interventions have a positive effect on outcomes such as
rehospitalisation rates, emergency department visits, patient
satisfaction, or health care cost [4, 9].
To date, in Germany there are few established stan-
dards for cross-sectoral communication related to ar-
ranged admission and discharge planning. Recent
changes to German federal laws and regulations aim to
improve transitions between care sectors. For example,
the Act to Enhance Competition in Statutory Health In-
surance (Gesetz zur Stärkung des Wettbewerbs in der
gesetzlichen Krankenversicherung) aims to improve qual-
ity and efficiency of health care by enhancing competi-
tions amongst care providers and sickness funds. A
further example is the Act to Act to Promote Health
Care in Statutory Health Insurance (Gesetz zur Stärkung
der Versorgung in der gesetzlichen Krankenversicherung),
which aims to improve continuity of patient’s care when
discharged from hospital to other care providers. Still,
fragmentation in care remains a complex challenge.
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With effect as of October 1st 2017, hospitals in Germany
are obligated to offer a structured discharge planning to
all patients according to the framework contract regard-
ing hospital discharge management (“Rahmenvertrag
über ein Entlassmanagement beim Übergang in die Ver-
sorgung nach Krankenhausbehandlung nach § 39 Abs. 1a
S.9 Sozialgesetzbuch V”). However, this framework con-
tract does not demand to conduct pre-hospital interven-
tions to improve the admission process.
In the presented study, a structured admission and
discharge management programme (VESPEERA) includ-
ing follow-up care in general practices will be tested,
thus providing a patient-centred and quality optimising
enhancement of usual care.
The overall aim of this study is the development, im-
plementation and evaluation of several transitional care
components in general practitioners (GP) and hospitals.
Objectives
Overall, the VESPEERA program is expected to reduce the
number of avoidable rehospitalisations and emergency care
contacts, to improve patient safety and patient involvement,
to reduce overuse, underuse and misuse of health care, to
improve the continuity of care and to improve interprofes-
sional and cross-sectoral communication between patients,
hospitals, GP-practices and the sickness fund “Allgemeine
Ortskrankenkasse (AOK) Baden-Wurttemberg”.
Methods/design
An open prospective quasi-experimental trial will be con-
ducted in multiple centres. Development of study material
has started in October 2017. Recruitment of patients and
implementation of study components (intervention phase)
has started in May 2018 and will last through September
2019, comprising a total of 17months. Participants can be
enrolled until September 2019. All evaluations and publi-
cations are planned to be completed by the end of
September 2020. Figure 1 illustrates the study timeline.
Study setting
The VESPEERA programme will be implemented in 25 hos-
pital departments and 115 general practices in 9 predefined
geographical areas in the federal state Baden-Wurttemberg
in South-Germany. Hospitals sign a participation contract
according to §140a SGB V. The intervention region can
be expanded if hospitals from other districts are willing to
participate. However, hospitals outside the intervention
region are not actively invited to participate. A sample of
50 GP-practices within the same federal state but outside
the intervention region will serve as control sites for the
patient survey.
Study population / eligibility criteria
GP-practices within the intervention region have to par-
ticipate in GP-centred care (Hausarztzentrierte Versor-
gung/ HzV). GP-centred care is a programme where,
amongst others, the GP has a gate-keeping function (fur-
ther description of the programme provided by Wensing
et al. [13]. Furthermore, Gp-practices have to employ a
Care Assistant in General Practice (Versorgungsassisten-
tin in der Hausarztpraxis/ VERAH). Inclusion criteria
for patients are age of 18 years and older, ability to give con-
sent, insurance with the sickness fund AOK Baden-Wurt-
temberg, participation in GP-centred care according to § 73b
SGB V, and at least one hospitalization during the interven-
tion phase. Patients residing in long-term care facilities are
excluded from study participation.
Intervention group
The VESPEERA programme comprises recommended
practices regarding discharge and care management,
which is reinforced by laws (§ 11 Abs. 4 SGB V, § 39 Abs. 1a
SGB V, § 112 Abs. 2, Satz 5 SGB V). The planned interven-
tion picks up these regulations for optimal care and offers
suggestions for their implementation and enhancement. Pa-
tients will not be randomly assigned to a study arm, but re-
ceive different intervention components based on the point
Fig. 1 VESPEERA study timeline. Each study arm will receive different intervention components based on the point of study enrolment and the
patient’s medical need, including structured assessment prior to admission and after discharge, automatically generated information for physicians and
patients, a telephonic discharge conversation between hospital and general practice as well as a telephone monitoring for patients with a higher risk
of rehospitalisation
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of study enrolment and the patient’s medical need (see
Table 1 – adjusted SPIRIT figure).
Assessment for Admission (A): Before a planned hos-
pital admission, the VERAH collects patient information
on basic data, admission diagnosis, medical history,
existing prescriptions, medication plans and other med-
ical information, social, living and legal situation, com-
munication and care needs.
Admission letter and accompanying patient brochure
(B): Based on the assessment for admission, an admis-
sion letter which also specifies how and when the prac-
tice is available by phone for the hospital staff is created.
Patients receive a brochure that informs and prepares
for the hospital stay.
Telephonic discharge conversation between GP-practices
and hospital (C): For patients with complex interventions,
medications or post-hospital care needs, a structured tele-
phonic discharge conversation supports cross-sectoral ex-
change of information and clarification of responsibilities
between the participating hospital and the responsible GP.
In case of need, the AOK can be contacted to support the
discharge process for example by providing medical prod-
ucts/ devices etc. in time.
Determination of HOSPITAL Score and patient dis-
charge information (D): The participating hospitals col-
lect data to determine the HOSPITAL Score, a score
that indicates the risk for rehospitalisation within 30
days after discharge [14]. The score is communicated to
the GP via the discharge letter. At the time of discharge,
the patient receives patient discharge information, which
summarizes the documents that the patient receives,
follow-up care and appointments after discharge as well
as different contact persons according to the respective
care needs.
Assessment for planning of follow-up care (E): After
hospital discharge, the patient has an appointment in the
GP-practice (in case of need: home visit) with the VERAH.
They conduct an assessment to determine the patients’
need for follow-up treatment and care. The GP receives a
summary of the assessment, disclosing the patients’ care
needs. Then, follow-up appointments, prescriptions and
applications (such as rehabilitation or home care) can be
determined and recorded. The patient receives a short
summary of the arranged follow-up care plan. Based on
the HOSPITAL Score, the GP determines the patients’ en-
rolment into the follow-up telephone monitoring. Patients
with an intermediate or high risk for rehospitalisation, ac-
cording to the HOSPITAL Score, should be enrolled in
the follow-up telephone monitoring. For patients treated
in a non-participating hospital, GP-practices have the op-
tion to gather data to determine the HOSPITAL Score.
All data necessary to determine the score can be extracted
from the discharge letter.
Post discharge telephone monitoring (F): If the HOS-
PITAL Score indicates an intermediate or high risk for
rehospitalisation, the GP-practice coordinates and ac-
companies follow-up care through a structured tele-
phone monitoring, which is limited to a time frame of 3
months after hospital discharge. The GP individually de-
fines the content and frequency of the telephone moni-
toring, which is executed by the VERAH. The first
phone call should be scheduled within the first 2 weeks
after discharge. The last phone call should be scheduled
3 months after discharge. Any phone calls in between
are defined in their interval by the GP.
Control group
Using propensity score matching a control group from
non-participating HzV-GP-practices in non-participating
districts is built. Using claims-based data, age, gender,
practice size and length of enrolment in GP-centred care
and the district are considered to build the control
group on practice level; to build a patient control group,
Table 1 Intervention components for all study arms
Interventions Study arm 1:
planned admission
into a participating
hospital
Study arm 2:
planned admission
into a non-
participating
hospital
Study arm 3:
unplanned
admission into
a participating
hospital
Study arm 4:
unplanned
admission into a
non-participating
hospital
Study arm 5:
control
group, not
participating
in VESPEERA
GP-practice Interventions in the GP-practice
before admission:
(A) assessment for admission
(B) admission letter and patient brochure
X X
Hospital Interventions in the hospital:
(C) telephonic discharge conversation
(D) determination of HOSPITAL-Score
and patient discharge information
X
GP-practice Interventions in the general practice
after discharge:
(E) assessment for planning of follow-up care
(F) telephone monitoring, depending on
the risk for rehospitalisation
X X X X
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age, gender, indication group and Charlson Comorbidity
Index are used. Patients in the control group are not
participating in the study and do not receive any inter-
vention components.
The control group for the patient survey comprises pa-
tients that from approx. 50 comparable HzV-practices out-
side the intervention region. The inclusion criteria of the
intervention group apply for patients of the control group.
Implementation strategies
Several strategies have been chosen in order to support
the implementation of the VESPEERA programme. First,
the CareCockpit software is used, providing a platform
to GP-practices that assists with organising patient infor-
mation, organising care planning, guidance through as-
sessments and automatic generation of documents. The
CareCockpit is routinely used in Baden-Wurttemberg
within the practice-based case management programme
PraCMan (Hausarztpraxis-basiertes Case Management))
and is now enhanced by an additional module for the
VESPEERA programme [15]. GP-practices receive the
CareCockpit-software free of charge. Second, representa-
tives of all stakeholders, thus clinicians, GPs, patients,
sickness funds and researchers, have been involved in
the development of assessment instruments and study
documents in order to increase acceptance and utilisa-
tion. In several workshops the intervention components
and all their items were discussed with regard to its rele-
vance, information value, feasibility, and degree of sensi-
tivity as well as wording. Third, GPs and VERAHs will
participate in a workshop to be instructed in software
utilisation and study processes. The workshops are deliv-
ered in a train-the-trainer format, i.e. the study team
trains a certain number of GPs who then lead regional
workshops for their participating colleagues. Fourth, par-
ticipating hospitals will hand in a description of their in-
dividual implementation plan. In order to facilitate the
integration of study components into clinical processes,
different approaches are suitable for different hospitals.
Therefore, each hospital will provide information on
how they will ensure the identification of study patients,
the use of the admission letter, the execution of the tele-
phonic discharge conversation, the dissemination of the
patient discharge information, and the determination of
the HOSPITAL Score. Hospitals can choose to either in-
tegrate the intervention components into their medical
information system or to choose a paper-based solution,
depending on their processes. Additionally, hospitals are
offered two options to provide the patient discharge in-
formation: (a) hospitals use the template provided by the
study team or (b) hospitals integrate the elements of the
study template into their own documents. Fifth, all
stakeholders will receive feedback reports in form of
benchmarking reports in September 2018, June 2019
and December 2019. The feedback reports are based on
claims data, data from the CareCockpit and patient sur-
vey data, aggregated on a hospital / GP-practice level.
The feedback reports will be discussed in moderated inter-
disciplinary feedback meetings. GPs, representatives of the
hospitals as well as patients will participate in these meet-
ings and discuss options for potential improvement. Add-
itionally, hospitals and GP-practices will receive expense
allowances for conducting patient-related care services as
well as lump sums for study organisation and participation
in workshops and feedback meetings.
Data sources
Data sources for the evaluation are claims-based data
from AOK Baden-Wurttemberg, data from the Care-
Cockpit software, primary data in the form of patient
surveys in the intervention group as well as a control
group, and data collected in participating hospitals in
order to determine the HOSPITAL Score. This includes
haemoglobin and sodium levels, length of stay, type of
admission (elective vs. non-elective), discharge from an
oncology service or execution of an oncological treat-
ment, any OPS-coded procedure and number of hospital
stays in the last 12 months.
CareCockpit data includes the pseudonym generated
for data linkage, diagnoses, the medical question for ad-
mission, information on previous antibiotic prescrip-
tions, living situation, long-term care related items (such
as ADL and IADL-scale), medical information (such as
pain, wounds, alarming symptoms for medical emergen-
cies, PHQ-2 instrument), compliance to medicinal ther-
apy, the items of the HOSPITAL Score as well as
process data (provision of information to patients, infor-
mation on whether any follow-up care has been initiated
and successfully executed).
The patient survey questionnaire includes the follow-
ing instruments: sociodemographic questions, the vali-
dated EQ-5D for health related quality of life [8] as well
as selected items from the validated PEACS-instrument
for satisfaction with cross-sectoral care concerning the
admission and discharge process [16]. Patient surveys
are conducted in GP-practices belonging to the inter-
vention group as well as GP-practices that build a con-
trol group with all patients who, in the first (t0) and in
the last 3 months of the intervention phase (t1) respect-
ively come into their GP-practice after a hospital stay.
The intervention phases can vary between the
GP-practices of the intervention group depending on
when the respective practice actually started its partici-
pation in VESPEERA.
Outcomes
The primary outcome is the number of rehospitalisations
due to the same indication (three-digit ICD-10-GM code)
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within a time frame of 3 months (90 days) to the out-
patient sector. This outcome is collected from claims-data
on a case level, meaning that each patient can have more
than one rehospitalisation, whereof all are considered in
the analyses.
The following indicators have been defined as second-
ary outcomes and are based on pseudonymised
claims-data, data collected within the CareCockpit soft-
ware in GP-practices as well as patient survey data:
1. number of rehospitalisations due to the same
indication (three-digit ICD-10-GM code) within a
time frame of 30 days
2. number of hospitalisations due to ambulatory care-
sensitive conditions [17]
3. number of patients discharged to the outpatient
sector from a participating hospital where the
prescription of medication is delayed [18]
4. number of patients discharged to the outpatient
sector from a participating hospital where referral
to other health practitioner/s (Heilmittel) is delayed
5. number of patients discharged to the outpatient
sector from a participating hospital where
prescription for medical products/devices
(Hilfsmittel) is delayed
6. number of patients discharged from a participating
hospital who use emergency or rescue services
(emergency medical service (Ärztlicher
Bereitschaftsdienst), emergency ambulance
(Notarztwagen), ambulance emergency response
vehicle (Notarzteinsatzfahrzeug), ambulance, rescue
helicopter (Primärtransport – Luft) within a time
frame of 3 months
7. average care cost per year and patient participating
in the VESPEERA programme
8. patient-reported experiences and health-related out-
come of cross-sectoral care using the German ver-
sion of the instrument Patients’ Experiences Across
Health Care Sectors (PEACS) [16]
9. health-related quality of life, using the instrument
EuroQol (EQ-5D) [19].
Recruitment
All eligible GP-practices located within the predefined
districts will be contacted by the HÄVG (Hausärztliche
Vertragsgemeinschaft, HÄVG, the organisation that
manages the GP-centred care contracts for the German
Association of General Practitioners) via fax or on other
communication channels such as newsletters and in
continuing education workshops. If interested in partici-
pation, GPs and VERAHs sign up for the training de-
scribed above. During the training they will receive
detailed information about the study and sign the in-
formed consent form.
Participating practices as study sites will check the in-
clusion criteria for a) patients with a planned hospital
admission and b) patients after discharge after an un-
planned hospital stay, provide the study information,
and receive the signed informed consent forms which
remain at the study site.
For the recruitment of the control group for the pa-
tient survey, GP-practices outside the intervention re-
gion will check the inclusion criteria for patients after
hospital discharge. They hand out the patient survey
questionnaire to eligible patients. Patients give their con-
sent by filling in the anonymous questionnaire. Controls
for the patient survey are recruited by GP-practices out-
side the intervention region.
Sample size calculation
Since large-scale implementation of the VESPEERA pro-
gram in a geographical region was intended, the number
of participating GPs and hospitals was not restricted.
Based on the number of GP-practices who participate in
HzV-Care and the number of GP-practices who partici-
pate in the PraCMan programme, a number of 115
GP-practices are expected to participate. An estimation
of the patient sample size was made using claims-data
and several assumptions for hospitalisation rates, rates
for planned and unplanned admissions, rates of patients
with a high risk of rehospitalisation as well as drop-out
rates. Assumptions were made based on analyses of
AOK claims-data. Admissions are expected to be
planned and unplanned in 50% of the cases, respectively.
56% of planned admissions are made by a GP and there-
fore can be included in the VESPEERA programme. 40%
of planned admissions are cases that are expected to be
treated in a participating hospital department. After dis-
charge, we calculated with a 20% drop-out rate for pa-
tients who are transferred into a nursing home, who
pass away or who do not seek GP contact after dis-
charge. 60% of discharged patients are expected to have
a risk of rehospitalisation (HOSPITAL Score indicating
an intermediate or high risk for rehospitalisation).
Figure 2 gives an overview on the sample sizes in each
study arm. Given the estimated sample size, we can esti-
mate the effect size (based on the hospitalisation rates
after the intervention) that can be detected. Based on
claims-data different numbers of hospitalisations can be
expected for each of the intervention groups. The alpha
level is set to 5%. The following power considerations
are based on chi square tests (to test for group differ-
ences) and adjusted for the hierarchical structure of the
data. The implemented models in the primary analysis
will most likely lead to even higher power values. How-
ever, we consider the hierarchical structure of the data
with cases nested in patients nested in hospitals or prac-
tices, respectively. A relatively high ICC (0.3) can be
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expected when considering measurements within pa-
tients, however the number of cases per patient will be
relatively small (approx. 1.6 cases per patient). The clus-
tering by hospitals or practices is taken into account
with an expected number of approx. 540 patients per
hospital and a presumed ICC of 0.03, which is a realistic
value in health services research [20]. Furthermore, we
assume a rate of re-hospitalisations of 23% in the control
group. With a power of 80%, the following reductions in
each of the intervention groups can be shown: For study
arm 1 a sample size of 1905 cases can be expected.
Hereby, a reduction of approx. 8% (from 23% to approx.
15%) can be shown. The control group will be matched
and, therefore, the sample size will be the same. For
study arm 2 when compared to the control group, the
same reduction is detectable, as the same number of
cases can be expected as in study arm 1. In a last step,
both the study arms 3 and 4 are compared to the control
group using a level of significance of 2.5%. In study arm
3, we expect a sample size of 3266 and, thus, a reduction
of approx. 7% (from 23 to 16%) can be shown. In study
arm 4, a sample size of 4899 hospitalizations can be ex-
pected which allows to show a reduction of approx. 6%
(from 23 to 17%).
Data collection and management
Primary and secondary outcomes, as well as patient
characteristics, are extracted from claims-data at the
health insurer involved, CareCockpit data and primary
data from a patient survey.
Claims-based data are collected for a time frame start-
ing 6 months before baseline until 3 months after the
intervention phase. Data from the CareCockpit is trans-
ferred along with administrative data each quarter year.
For the conduction of the patient survey, GP-practices
are informed in advance on when to conduct the survey
and they receive all material needed including the pa-
tient questionnaires, the sealed box to collect them, and
detailed information on how to conduct the survey in
the practice. The patients are asked in the practice by
their physician after discharge to take part in the survey
by filling in the questionnaire in the practice. Question-
naires will be handed out to all eligible patients per prac-
tice and time point in both intervention and control
practices. The sealed boxes with filled-in questionnaires
will be sent by mail using an enclosed post-paid box dir-
ectly to the aQua-Institute.
The hospitals have the choice to either integrate the
questionnaire into their hospital information system as an
electronic questionnaire (transfer to the aQua-Institute via
secure file transfer protocol (SFTP)-servers) or to fill in
paper-based questionnaires that are sent to the
aQua-Institute via mail using enclosed post-paid envelopes.
If GP-practices are responsible for determining the HOS-
PITAL Score, the items of the HOSPITAL Score are part of
the assessment for planning of follow-up care within the
CareCockpit and will be transferred to the evaluating insti-
tutions along with other CareCockpit data. All data neces-
sary to determine the score can be extracted from the
discharge letter.
As the intervention is implemented in a pragmatic study
design, differences in quality between the GP-practices
and hospitals can occur. For quality assurance purposes,
all GP-practices are therefore continuously being con-
tacted via telephone by the study central office. Within
the phone calls, recruitment status in the GP-practice is
being checked and support with the implementation is of-
fered. Additionally, any issues that occur with the imple-
mentation will be addressed in feedback meetings.
Furthermore, the CareCockpit software guides through
the assessments.
Data analysis
The outcome evaluation is divided into a primary analysis
and secondary analyses. Design and analysis of the
claims-data based evaluation will closely follow a recently
published US-study on reduction of rehospitalisations in
high-risk patients [2]. They are well-grounded and estab-
lished in the literature on programme evaluation, espe-
cially in econometrics and quantitative social science, and
increasingly in health systems research [21–24].
Fig. 2 Expected sample sizes in all four study arms
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Primary analysis
In the primary analysis, a difference-in-difference model is
applied [21, 25, 26]. The change of the primary outcome
(before vs. after the intervention) of each intervention
group will be pairwise compared to the control group. Put
in a simple way, the following model will be estimated:
rehospitalisationt;i ¼ β0 þ βTx timet;i
þ βIx interventioni
þ βIxTx intervention : timeð Þt;i:
The index t describes the point in time, i is the index
for the considered observation. The following parame-
ters will be estimated:
 β0: intercept
 βT: effect of time; the general change from before to
after the intervention
 βI: difference between groups at baseline
 βIxT: difference between the change (before and after
comparison) in the control and in the intervention
group; the main parameter for the outcome
evaluation
The assumptions of this model are sufficiently discussed
in the literature. The parameter βIxT is the main parameter
to evaluate the effectiveness of the intervention, describing
the difference in changes between the two groups over time.
The above model is adjusted for the covariate service level
of the hospital and the location (general allocation to dis-
tricts). Other covariates will be already considered during
the matching procedure when generating the control group.
The primary outcome is binary. Thus, logistic regres-
sion models will be applied. Furthermore, there is a hier-
archical structure underlying the data, with cases nested
in patients, and patients nested in practices or hospitals,
respectively. This structure is considered in the model
by including random intercepts at each level. The com-
bination of random and fixed effects results in a mixed
logistic regression model. A compound symmetry correl-
ation structure will be assumed when fitting the models.
In the primary analysis, one model per intervention
arm will be applied which leads to the need of an adjust-
ment of our testing procedure for multiple testing. In
order to meet the global level of significance of 5%, the
following procedure will be applied: Study arm 1
(planned admission into a participating hospital) is ex-
pected to show the strongest effect. Therefore, this com-
parison will be considered using the full α-level of 5%. If
the null hypothesis of no intervention effect can be
rejected, the second study arm is tested at the same
level. In a last step, the study arms 3 and 4 are tested
simultaneously by splitting the level of significance
equally according to Bonferroni to 2.5% each.
Secondary analysis and sensitivity analysis
In addition to the primary analysis, further analyses will
be conducted. First, again using the primary outcome
but including 12 time points (six before the intervention
and six after the intervention (measured month-wise),
time trends before and after the intervention will be
compared using interrupted time-series-models [27, 28].
Secondary endpoints will be analyzed using the same
strategy as used in the primary analysis with adjustments
of the models as necessary.
Furthermore, descriptive statistics of all collected data
will be performed. Continuous variables will be de-
scribed using means, standard deviations, median, mini-
mum, maximum, and first and third quartile, separately
for each intervention group and the control groups as
well as for the total population. Categorical variables will
be reported using absolute and relative frequencies.
As claims-based data are used, no missing values are
expected to occur, therefore no imputation procedures
need to be carried out.
Analysis sets
The primary analysis will be based on the intention-to-treat
sample. This means that, in the analysis, patients will be
considered in the treatment arm they were assigned to even
if, for instance, not all interventions that were planned in
this arm were delivered. In sensitivity analyses, the
per-protocol set will be analyzed where these patients will
be omitted. Patient to be excluded in this set will be defined
before the analysis is performed. In a further as-treated-set
the omitted patients will be included again but assigned to
the treatment arm that describes best the treatment they
actually received.
Ethics, data protection and security and dissemination
The study protocol has been submitted to and approved
by the ethics committee of the Medical Faculty Heidel-
berg as well as the ethics committee of the State Medical
Council of Baden-Wurttemberg prior to the start of the
study. Any amendments to the protocol are dissemi-
nated to GP-practices via post and have to be confirmed
via fax, GP-practices will be called until the study central
office receives a signature as confirmation.
The regulations of the Data Security Law of Baden-
Wurttemberg (Landesdatenschutzgesetz), the German
Federal Data Security Law (Bundesdatenschutzgesetz), re-
spectively, are met. All responsibilities concerning data man-
agement and analysis as well as access to data is declared in
a separate and elaborate data protection concept which is
part of the contractual agreement between consortium part-
ners and has been approved by a data security officer.
To enhance transparency and integrity, the SPIRIT check-
list was used during compilation of this study protocol [29].
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Discussion
We expect to receive results on the effectiveness of the
components included on the outcomes that guide the
evaluation. Based on the results, we will adjust the inter-
vention with regards to content and possibly define the
scope of the patient collective that benefits most from
the intervention. An implementation in area-wide usual
care and hence standards for transitional care that in-
volve care providers from both the inpatient and the
outpatient sector is well sought. Thereby, we will be able
to contribute to the scientific knowledge on admission
and discharge management in general and especially in
Germany.
We also hope to lay the foundation for bringing to-
gether stakeholders involved in cross-sectoral care in
order to stimulate exchange and to offer a platform to
collectively tackle the challenges of transitions in care.
However, this study has a number of limitations. The
implementation of intervention measures means add-
itional time expenditure for hospitals, GP-practices and
patients. Therefore, the acceptance and intended provision
of study components might be a critical factor. Neverthe-
less, we expect appointments especially within the
GP-practice to be more structured and targeted. Accept-
ance of the intervention amongst others will be investi-
gated in an accompanying process evaluation. A separate
study protocol for the process evaluation will be handed
in for publication.
Study results will be published in final reports to the fund-
ing agency, articles in peer-reviewed journals, and will be
presented on national and, if eligible, international confer-
ences. Furthermore, all participating GP-practices and hos-
pital centers will receive feedback reports and the final
report. A project-related website addresses any study-related
content and serves as an instrument to communicate any
news relating to the study.
Trial status
The study protocol on hand is the protocol version 2.0
from July 30th 2018. Recruitment started on June 15th
2018 and will approx. be completed by the end of Sep-
tember 2019.
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